NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
Clinical Trials
13 trialsNCT04565665 2026-03-10
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05672355 2026-03-05
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 2 Recruiting
NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT05022446 2026-02-13
The Impact of COVID-19 on Pulmonary Procedures
M.D. Anderson Cancer Center
Recruiting
NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
NCT04500600 2026-01-20
Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Active not recruiting
NCT05102656 2025-11-17
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04551378 2025-10-21
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
M.D. Anderson Cancer Center
Recruiting
NCT04650178 2025-10-14
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials
M.D. Anderson Cancer Center
Active not recruiting
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT05683353 2025-05-31
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
Peking University First Hospital
Active not recruiting
NCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated